Abstract:Ghrelin is a novel 28-amino acid peptide with an n-octanoyl ester in the serine 3 that has recently been discovered in rat and human gastrointestinal tract, as an endogenous ligand for growth hormone (GH) secretagogue receptor 1. Ghrelin is produced and stored in granules of the special neuroendocrine cells (A-like cells), located mainly in oxyntic mucosa 2. Ghrelin stimulates GH release and induces a positive energy balance by stimulating food intake and decreasing fat use 3. Ghrelin also has numerous peripheral actions including direct effects on exocrine and endocrine pancreatic functions, carbohydrate metabolism, gastric secretion, stomach motility, and sleep 4. Recently, some authors revealed that administration of ghrelin during reperfusion had protective effects on myocardial ischemia reperfusion injury, including reduced ischemic volume, improvements in coronary flow, and attenuation of lipid peroxidation in a rat model 5. But the exact effect of ghrelin on focal cerebral ischemia reperfusion and the mechanism underlying it are still unknown. Focal cerebral ischemia in adult male Sprague-Dawley rats (weighing 250–280 g) was induced by MCAO (middle cerebral artery occlusion) for 90 min with an intraluminal filament according to the method previously described by Longa 6. Rat ghrelin was administered intraperitoneally (160 μg/kg) 30 min before MCAO and at the beginning of reperfusion. Brain samples were obtained 24 h after MCAO. In this study, we demonstrated that systemic administration of ghrelin significantly reduced infarct volumes from MCAO (data shown in Figure 1A). The protective effect of ghrelin on cell apoptosis and neuronal degeneration after ischemia reperfusion injury was evaluated by TUNEL and Fluoro-Jade B staining, a kind of polyanionic fluorescein derivative that specifically bound to degenerating neurons. In ghrelin-treated group, the number of TUNEL-positive cells and degenerating neurons in the peri-infarct area decreased significantly (Figure 1B,C). Given the fact that ghrelin can pass through the blood–brain barrier 7, these findings suggest that peripherally administered ghrelin enters the brain parenchyma and exerts neuroprotective effects on cerebral ischemia reperfusion. The inhibitive effect of ghrelin on apoptosis was supposed to be related to the activation of PI3K/AKT signaling pathway by the phosphoralation of Akt in an endothelial cell injury 8. Reactive oxygen species (ROS) have been implicated in the pathogenesis of cerebral ischemia reperfusion injury 9. These oxygen-free radicals are directly toxic to neurons and initiate a free radical-mediated cascade causing neuronal damage. To assess the effect of ghrelin on ROS, we evaluated the production of superoxide anion, an important reactive oxygen species (ROS) using DHE (dihydroethidium). In this study, we found superoxide anion production was enhanced after reperfusion, and ghrelin treatment could attenuate it (Figure 2). These might be related to the mechanism that ghrelin could inhibit NADPH oxidase activation and reduce ROS production 10. In summary, we have demonstrated that peripheral administration of ghrelin could protect neurons from ischemic injury caused by MCAO. The protective effects of ghrelin appear to be related with an inhibition of apoptosis and oxidative stress. Our results suggest that ghrelin can function as a neuroprotective agent, and administration of ghrelin may be a novel therapeutic strategy for the treatment of ischemic stroke. This study was supported by National Natural Sciences Foundation of China (30801183), Key Clinical Disciplines Program of Chinese Health Ministry and Grants of Health Bureau of Zhejiang Province (2012).

Ghrelin prevents lethality in a rat endotoxemic model through central effects on the vagal pathway and adenosine A2B signaling : Brain ghrelin and anti-septic action

Ghrelin Inhibits Proinflammatory Responses and Prevents Cognitive Impairment in Septic Rats.

Effect of Cholinesterase Inhibitor Galanthamine on Circulating Tumor Necrosis Factor Alpha in Rats with Lipopolysaccharide-Induced Peritonitis

Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats.

Therapeutic Effects of Ghrelin on Endotoxic Shock in Rats

Ghrelin attenuates the inflammatory response induced by experimental endotoxemia in mice

Ghrelin Inhibits Sympathetic Nervous Activity in Sepsis.

Ghrelin Prevents Neuronal Apoptosis and Cognitive Impairments in Sepsis-Associated Encephalopathy

Ghrelin Protects Mice Against Endotoxemia-Induced Acute Kidney Injury.

Effects of Ghrelin on Pulmonary NOD2 Mrna Expression and NF-κB Activation when Protects Against Acute Lung Injury in Rats Challenged with Cecal Ligation and Puncture

Ghrelin/GHSR Axis Induced M2 Macrophage and Alleviated Intestinal Barrier Dysfunction in a Sepsis Rat Model by Inactivating E2F1/NF- κ B Signaling

Ghrelin Attenuates Lipopolysaccharide-Induced Acute Lung Injury Through NO Pathway.

Ghrelin Attenuates Secondary Brain Injury Following Intracerebral Hemorrhage by Inhibiting NLRP3 Inflammasome Activation and Promoting Nrf2/ARE Signaling Pathway in Mice

Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves.

The Inhibitory Effect of Ghrelin on Sepsis-Induced Inflammation is Mediated by the MAPK Phosphatase-1.

Ghrelin Attenuated Cerebral Ischemia Reperfusion Injury in Rats

Ghrelin protects small intestinal epithelium against sepsis-induced injury by enhancing the autophagy of intestinal epithelial cells.

Ghrelin Alleviates Intestinal Dysfunction in Sepsis Through the KLF4/MMP2 Regulatory Axis by Activating SIRT1

Ghrelin inhibits inflammatory response and apoptosis of myocardial injury in septic rats through JAK/STAT signaling pathway

Ghrelin Attenuates Intestinal Barrier Dysfunction Following Intracerebral Hemorrhage In Mice

Ghrelin attenuates intestinal ischemia/reperfusion injury in mice by activating the mTOR signaling pathway